Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
250 The second RCT reported in a much larger sample (131 BCG patients, 134 placebo patients) no differences in response rate between treatment arms (21% in the BCG group compared to 12% in the placebo groups) at seven months with 95% of patients in each group reporting at least one AE
This process can enhance nutrient and oxygen delivery to areas requiring healing
Tirzepatide significantly improves glycemic control in individuals with type 2 diabetes or prediabetes
Previous research demonstrates that ESC alleviates hyperlipidemia by decreasing lipid accumulation, restoring serum HDL-C levels, and inhibiting MMP-9 production and LDL oxidation (Wang et al
A combined strategy improves the solubility of aggregation-prone single-chain variable fragment antibodies
Kuhnen, P
US$ 21.63
US$ 27.79
US$ 20.59
US$ 21.25
US$ 24.98
US$ 21.73
US$ 25.61
US$ 28.37
US$ 20.78
US$ 27.31
US$ 21.19
